newsfilter
← Latest News
GlobeNewswire·

TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026

  • Cytek Biosciences, Inc. (NASDAQ: CTKB) was named to TIME's 2026 list of America's Growth Leaders in partnership with Statista.
  • The inaugural ranking identifies top-performing US publicly listed companies with exceptional growth, financial stability, & stock performance over the past five years.
  • CEO Wenbin Jiang stated the recognition reflects the team's dedication, customer trust, & commitment to making high-parameter cell analysis more accessible.
  • The company's Full Spectrum Profiling™ (FSP®) technology is cited in over 3,200 peer-reviewed publications to advance research in cancer, cell therapies, vaccines, & emerging diseases.
  • Cytek's product portfolio includes Aurora™, Northern Lights™, Orion™, Amnis®, & Guava® systems designed for high-resolution, high-sensitivity cell analysis.
  • Most Cytek products are for research use only, with limited clinical availability for the Northern Lights-CLC system & certain reagents in China & the European Union.
  • The company is headquartered in Fremont, California, with global offices & distribution channels.
  • Forward-looking statements in the release are subject to risks including geopolitical conditions, export controls, funding policies, competition, & supply chain dependencies.